Pure Global AI
NCT06404268Not yet recruiting

Facilitating Neuroplastic Changes of Acute Stroke Survivors

Facilitating Neuroplastic Changes of Acute Stroke Survivors With Severe Hemiplegia
University of Maryland, BaltimorePhase 1/2ClinicalTrials.govdeviceDevice trial
Verified
Study focus
Disease/Condition
Stroke
Drug/Device/Intervention
Motor relearning training
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
University of Maryland, Baltimore
Timeline & enrollment
Phase
Phase 1/2
Start date
May 01, 2024
End date
Apr 01, 2029
Enrollment
100 participants
Primary outcome

Fugl-Meyer Lower Extremity (FMLE)

Summary

This project will develop a wearable rehabilitation robot suitable for in-bed acute stage
 rehabilitation. It involves robot-guided motor relearning, passive and active motor-sensory
 rehabilitation early in the acute stage post-stroke including patients who are paralyzed with
 no motor output. The early acute stroke rehabilitation device will be evaluated in this
 clinical trial.

ICD-10 classifications
Stroke, not specified as haemorrhage or infarctionSequelae of stroke, not specified as haemorrhage or infarctionCerebral infarctionFamily history of strokeCerebral infarction, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06404268
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06404268 through Pure Global AI's free database. This Phase 1/2 trial is sponsored by University of Maryland, Baltimore and is currently Not yet recruiting. The study focuses on Stroke. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.